# Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP

> **NCT07662525** · NA · NOT_YET_RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Immune Thrombocytopenic Purpura

## Interventions

- **DRUG:** atorvastatin, NAC, and romiplostim

## Key facts

- **NCT ID:** NCT07662525
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07662525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07662525, "Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07662525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*